ByteDance’s AI drug unit Anew Labs raises $290M at $1.5B valuation, Reuters reports

ByteDance closed a $290M funding round for Anew Labs, its newly spun-off AI drug discovery unit, at a $1.5B valuation, Reuters reports, citing two sources familiar with the matter. Moreover, the company that owns TikTok will retain 56% of the business after this round, according to the same sources. According to the same reporting, HSG, […] This story continues at The Next Web